FORATOM, the Brussels-based trade association for the nuclear energy industry in Europe, made up of 15 national nuclear associations representing nearly 3,000 firms acts as the voice of the European nuclear industry in energy policy discussions with EU Institutions and other key stakeholders. A joint position paper was issued on 14th June 2021 by FORATOM and Nuclear Medicine Europe, urging the European Union to promote new research reactor capacity along with innovation in the sector and the design modification of the current fleet, in line with its Europe’s Beating Cancer Plan, to maintain the current level of medical radioisotopes supply.
The position paper highlights that every year, more than 9 million patients in Europe benefit from nuclear medicine in the diagnosis and treatment of illnesses such as cancer and cardiovascular or neurological disorders and explains the technicalities of nuclear medicine, presents the scope of the current nuclear medicine sector in the European Union as well as highlighting the challenges that have to be overcome both at regulatory and supply chain levels.
To read more please visit:
Source: FORATOM